Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Adicet Bio, Inc. issued pre-funded warrant to acquire 250,000 shares of Common Stock of warrant to RA Capital Management, L.P. and RA Capital Healthcare Fund, L.P. for exercise price of $0.0001 per share.
- Security
- warrant
- Shares
- pre-funded warrant to acquire 250,000 shares of Common Stock
- Purchaser
- RA Capital Management, L.P. and RA Capital Healthcare Fund, L.P.
- Consideration
- exercise price of $0.0001 per share
Exact text from the filing
On April 27, 2026, Adicet Bio, Inc. (the Company) entered into an exchange agreement with RA Capital Management, L.P. and RA Capital Healthcare Fund, L.P. (together, RA Capital) pursuant to which RA Capital exchanged 250,000 shares of the Company’s common stock, par value $0.0001 per share (Common Stock) for a pre-funded warrant (the Pre-Funded Warrant) to acquire 250,000 shares of Common Stock.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Adicet Bio, Inc. issued 250,000 shares of the Company’s common stock of common stock to RA Capital Management, L.P. and RA Capital Healthcare Fund, L.P. for exchanged 250,000 shares of the Company’s common stock ... for a pre-funded warrant.
- Security
- common stock
- Shares
- 250,000 shares of the Company’s common stock
- Purchaser
- RA Capital Management, L.P. and RA Capital Healthcare Fund, L.P.
- Consideration
- exchanged 250,000 shares of the Company’s common stock ... for a pre-funded warrant
Exact text from the filing
On April 27, 2026, Adicet Bio, Inc. (the Company) entered into an exchange agreement with RA Capital Management, L.P. and RA Capital Healthcare Fund, L.P. (together, RA Capital) pursuant to which RA Capital exchanged 250,000 shares of the Company’s common stock, par value $0.0001 per share (Common Stock) for a pre-funded warrant (the Pre-Funded Warrant) to acquire 250,000 shares of Common Stock.
View on SEC.gov